Hydrocephalus Market Expected to reach $10,178.6 million by 2030

According to a new report published by Allied Market Research, titled, “Hydrocephalus Market by Cause, Type, Diagnosis, Treatment, Age and Region: Opportunity Analysis and Industry Forecast, 2020-2030,” the global hydrocephalus shunt market was valued at $6907.5 million in 2020 and is projected to reach $10178.6 million by 2030, registering a CAGR of 4.0% from 2021 to 2030.

According to the National Institute of Neurological Disorders and Stroke (NINDS), hydrocephalus is an abnormal buildup of fluid in the ventricles (cavities) deep within the brain. This excess fluid causes the ventricles to widen, putting pressure on the brain’s tissues. Cerebrospinal fluid (CSF) is the clear, colorless fluid that protects and cushions the brain and spine. Normally, cerebrospinal fluid flows through the ventricles and bathes the brain and spinal cord before being reabsorbed into the bloodstream. The body typically produces enough CSF each day and absorbs the same amount. However, it can result in a buildup of CSF, when the normal flow or absorption of CSF is blocked. The pressure from too much CSF can keep the brain from functioning properly and cause brain damage and even death.

Moreover, shunt therapy is the most common way to treat hydrocephalus, which is caused by excessive cerebrospinal fluid in the brain, causing build-up and pressure that can lead to symptoms such as chronic headaches, vomiting, and abnormal head enlargement is projected to eventually lead to death.

The growth of the market is attributed to the rise in the geriatric population, and increase in the adoption of advanced programmable valves. Moreover, the increase in prevalence of brain disorders and injuries such as intraventricular hemorrhage, stroke, tumor, and several other types of CSF infections can result in the development of hydrocephalic conditions among patients. For instance, according to the National Institute of Health (NIH), hydrocephalus ex-vacuo, a type of hydrocephalus results from brain damage caused by stroke or injury.

Thus, the increase in neurological disorders has increased the chances of developing hydrocephalus condition, leading to a higher demand for advanced shunts for treating hydrocephalus, thereby, contributing toward the market growth. Moreover, according to a recent survey from the Hydrocephalus Association, approximately 18% of certain neurological procedures result in complications such as infection and extrusions and the head needs to be the same shape before and after surgery. This has led to competition among key players to develop the latest technologies to support the treatment process which has signed to the growth of the market. For instance, in 2018, Longeviti Neuro Solutions, launched its novel Invisishunt surgical implant solution. Invisishunt is a neurological implant that is surgically placed in the cranium to restore its natural contour while maintaining its proper position.

The impact of COVID-19 pandemic is expected to remain moderate for the global hydrocephalus market. The companies are facing a setback, owing to the lockdown, which led to a drop in the manufacturing and the patient flow reduced substantially.

However, this deleterious impact is expected to be compensated by the increase in demand for advanced programmable shunts for treating hydrocephalic patients worldwide. Likewise, the introduction of disruptive technologies such as “eShunt system” is all set to booster the growth of the hydrocephalus market post-pandemic.

However, despite the shunt's life-saving purpose, implantation has been riddled with high failure rates, causing multiple revisions and surgeries for an individual with the condition that may hamper the market growth. On the basis of cause, the market is categorized into congenital hydrocephalus and acquired hydrocephalus. The acquired hydrocephalus segment led the market in 2020, and is expected to retain its dominance during the forecast period.

By type, the market is segmented into communicating hydrocephalus and non-communicating hydrocephalus. The communicating hydrocephalus is categorized into normal pressure hydrocephalus, ex-vacuo hydrocephalus. The diagnosis segment is fragmented into CT scan, MRI, and ultrasound. The ultrasound segment led the market in 2020, and is expected to retain its dominance during the forecast period. Furthermore, on the basis of treatment, the market is categorized into surgery shunt insertion and ventriculostomy. The surgery shunt insertion segment led the market in 2020, and is expected to retain its dominance during the forecast period.

The age is categorized into Neonate & Pediatrics and Adults. The adult's segment exhibited the highest growth in 2020, and is expected to continue this trend during the forecast period. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for a majority of the global hydrocephalus shunt market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to a higher hydrocephalus prevalence rate along with well-developed healthcare infrastructure and favorable government reimbursement policies.

The report provides some of Key players operating in the global hydrocephalus market include Aesculap Inc., Integra Lifesciences, Karl Storz Se And Co. Kg, Proteses Inc., Medtronic Plc. and Natus Medical Inc. Further, the service provider of hydrocephalus is Boston Children’s Hospital, Anadolu Medical Center, Helios Hospital, Texas Children's Hospital, and Children's National Hospital.

Key Findings Of The Study

• By cause, the Acquired hydrocephalus segment was the highest contributor to the market in 2020
• By type, the Communicating hydrocephalus segment was the highest contributor to the market in 2020
• By diagnosis, the ultrasound segment was the highest contributor to the market in 2020
• By treatment, the Surgery Shunt Insertion segment was the highest contributor to the market in 2020
• By age, the Adults segment is expected to witness the fastest market growth during the forecast period
• By region, North America garnered the largest revenue share in 2020, whereas Asia Pacific is anticipated to grow at the highest CAGR during the forecast period.